Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/268065
Share/Export:
logo share SHARE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Oral Consumption of Bread from an RNAi Wheat Line with Strongly Silenced Gliadins Elicits No Immunogenic Response in a Pilot Study with Celiac Disease Patients

AuthorsGuzmán-López, María H.; Sánchez-León, Susana; Marín-Sanz, Miriam; Comino, Isabel; Segura, Verónica; Vaquero, Luis; Rivero-Lezcano, Octavio M.; Pastor, Jorge; Sousa Martín, Carolina; Vivas, Santiago; Barro Losada, Francisco CSIC ORCID
KeywordsShort-term oral challenge
RNAi wheat
33-mer
Gluten-free diet
Celiac
E82
Gliadins
Gluten
Issue Date18-Dec-2021
PublisherMultidisciplinary Digital Publishing Institute
CitationNutrients 13(12): 4548 (2021)
AbstractCeliac disease (CD) is a genetically predisposed, T cell-mediated and autoimmune-like disorder caused by dietary exposure to the storage proteins of wheat and related cereals. A gluten-free diet (GFD) is the only treatment available for CD. The celiac immune response mediated by CD4+ T-cells can be assessed with a short-term oral gluten challenge. This study aimed to determine whether the consumption of bread made using flour from a low-gluten RNAi wheat line (named E82) can activate the immune response in DQ2.5-positive patients with CD after a blind crossover challenge. The experimental protocol included assessing IFN-γ production by peripheral blood mononuclear cells (PBMCs), evaluating gastrointestinal symptoms, and measuring gluten immunogenic peptides (GIP) in stool samples. The response of PBMCs was not significant to gliadin and the 33-mer peptide after E82 bread consumption. In contrast, PBMCs reacted significantly to Standard bread. This lack of immune response is correlated with the fact that, after E82 bread consumption, stool samples from patients with CD showed very low levels of GIP, and the symptoms were comparable to those of the GFD. This pilot study provides evidence that bread from RNAi E82 flour does not elicit an immune response after a short-term oral challenge and could help manage GFD in patients with CD.
Publisher version (URL)http://dx.doi.org/10.3390/nu13124548
URIhttp://hdl.handle.net/10261/268065
Identifiersdoi: 10.3390/nu13124548
e-issn: 2072-6643
Appears in Collections:(IAS) Artículos




Files in This Item:
File Description SizeFormat
Celiac_Disease_Patients.pdf2,41 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work

Page view(s)

30
checked on Jul 7, 2022

Download(s)

6
checked on Jul 7, 2022

Google ScholarTM

Check


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.